Literature DB >> 19324911

Rituximab reduces the incidence of acute graft-versus-host disease.

Maximilian Christopeit, Vincent Schütte, Sebastian Theurich, Thomas Weber, Wilfried Grothe, Gerhard Behre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19324911     DOI： 10.1182/blood-2009-01-200527

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

Review 1.  Current and emerging strategies for the prevention of graft-versus-host disease.

Authors:  Sung Won Choi; Pavan Reddy
Journal:  Nat Rev Clin Oncol       Date:  2014-06-24       Impact factor: 66.675

2.  Towards a rational graft-versus-host disease (GVHD) prophylaxis: rituximab should not be forgotten.

Authors:  Marlies E H M Van Hoef
Journal:  Haematologica       Date:  2013-04       Impact factor: 9.941

3.  Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effects.

Authors:  Heather F Johnston; Yajing Xu; Jeremy J Racine; Kaniel Cassady; Xiong Ni; Tao Wu; Andrew Chan; Stephen Forman; Defu Zeng
Journal:  Biol Blood Marrow Transplant       Date:  2014-05-04       Impact factor: 5.742

4.  An improved bicistronic CD20/tCD34 vector for efficient purification and in vivo depletion of gene-modified T cells for adoptive immunotherapy.

Authors:  Isabel Vogler; Sebastian Newrzela; Sylvia Hartmann; Nadine Schneider; Dorothee von Laer; Ulrike Koehl; Manuel Grez
Journal:  Mol Ther       Date:  2010-05-11       Impact factor: 11.454

5.  Immune Suppression in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Thomas F Michniacki; Sung Won Choi; Daniel C Peltier
Journal:  Handb Exp Pharmacol       Date:  2022

6.  IL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation.

Authors:  Xiaoran Wu; Yi Tan; Qiao Xing; Shengdian Wang
Journal:  Protein Cell       Date:  2013-11-10       Impact factor: 14.870

7.  Overcoming immunological barriers in regenerative medicine.

Authors:  Johannes L Zakrzewski; Marcel R M van den Brink; Jeffrey A Hubbell
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

8.  Approaches for the prevention of graft-versus-host disease following hematopoietic cell transplantation.

Authors:  Erin Gatza; Sung Won Choi
Journal:  Int J Hematol Oncol       Date:  2015-08

9.  Graft versus host disease following liver transplantation: A case report.

Authors:  Changsong Zhang; Guangshun Yang; Yang Ling; Guihua Chen; Tianbao Zhou
Journal:  Exp Ther Med       Date:  2014-07-17       Impact factor: 2.447

Review 10.  Virotherapy as Potential Adjunct Therapy for Graft-Vs-Host Disease.

Authors:  Nancy Y Villa; Grant McFadden
Journal:  Curr Pathobiol Rep       Date:  2018-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.